Barclays initiated coverage of Claritev with a rating of Overweight and set a new price target of $28.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/29/2026 | $32.00 | Buy | Canaccord Genuity |
| 4/24/2026 | $28.00 | Overweight | Barclays |
| 1/12/2026 | $43.00 | Buy | Guggenheim |
| 1/9/2026 | $33.00 | Equal Weight | Wells Fargo |
| 10/21/2025 | $74.00 | Neutral → Buy | Citigroup |
| 5/29/2025 | $44.00 | Neutral → Overweight | Piper Sandler |
4 - Claritev Corp (0001793229) (Issuer)
4 - Claritev Corp (0001793229) (Issuer)
4 - Claritev Corp (0001793229) (Issuer)
4 - Claritev Corp (0001793229) (Issuer)
4 - Claritev Corp (0001793229) (Issuer)
4 - Claritev Corp (0001793229) (Issuer)
Claritev will use CodeTogether's AITrax to help measure adoption, cost, quality, and value across its enterprise AI-assisted software development initiatives. MCLEAN, Va. and WILMINGTON, Del., July 21, 2026 /PRNewswire/ -- Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the healthcare system, today announced it will use CodeTogether's AITrax to gain greater visibility into AI-assisted software development across its engineering organization. As AI-assisted development beco
Connected claims technology helps accelerate benefit payments for critical illness, accident, and hospital indemnity coverageWELLESLEY, Mass. and MCLEAN, Va., July 16, 2026 /PRNewswire/ -- Sun Life U.S., a leading provider of employee and government benefits, and Claritev, a healthcare technology, data and insights company, are working together to bring more efficiency to supplemental health coverage offered by self-funded employers. Claritev's machine-learning technology helps find diagnosis connections between employees' medical claims and supplemental health coverages – which include critical illness, accident and hospital indemnity – to help covered employees access the benefits they are
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its second quarter fiscal year 2026 financial results prior to market open on Friday, August 7, 2026, and hold a conference call at 8:00 am Eastern Time.A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck wi
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its second quarter fiscal year 2026 financial results prior to market open on Friday, August 7, 2026, and hold a conference call at 8:00 am Eastern Time.A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck wi
Q1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025 Net Loss of $73.6 million Adjusted EBITDA of $146.9 million increased 3.4% compared to Q1 2025 (Adjusted EBITDA Margin of 60.0% versus 61.4% in Q1 2025) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2026. "Claritev kicked off 2026 the same way we closed 2025, outperforming on the top and bottom lines with focused execution in sales, operations and financials. We are operating with confidence — confidence in our te
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter fiscal year 2026 financial results prior to market open on Thursday, May 7, 2026, and hold a conference call at 8:00 am Eastern Time. A live webcast of the conference call can be accessed through the Investor Relations section of the Company's website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck
Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible
Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti
HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio
8-K - Claritev Corp (0001793229) (Filer)
8-K - Claritev Corp (0001793229) (Filer)
8-K - Claritev Corp (0001793229) (Filer)
Canaccord Genuity initiated coverage of Claritev with a rating of Buy and set a new price target of $32.00
Barclays initiated coverage of Claritev with a rating of Overweight and set a new price target of $28.00
Guggenheim initiated coverage of Claritev with a rating of Buy and set a new price target of $43.00